Molecular Imaging

Alzheimer’s brain pathology differs based on sex

By Will Morton

Understanding gender and sex differences is crucial to identifying effective and equitable prevention and treatment.

January 27, 2026

How does F-18 flurpiridaz PET perform in routine clinical practice?

By Will Morton

A study provides real-world insights into the clinical implementation of F-18 flurpiridaz PET in a diverse group.

January 26, 2026

New study seeks to tailor RLT to individual patients

By Will Morton

A new clinical trial aims to determine how doctors can optimize targeted radioligand therapy (RLT) for men with prostate cancer.

January 26, 2026

Georgia ProtonCare Center enters asset purchase agreement with Emory

By AuntMinnie.com staff writers

Georgia ProtonCare Center has entered into an asset purchase agreement with Emory University.

January 22, 2026

Novel radiopharmaceutical therapy could help treat pleural metastases

By Will Morton

Previously, patients had been heavily treated with standard therapies, such as chemotherapy, immunotherapy, and radiation therapy.

January 22, 2026

Cardiac PET imaging predicts atrial fibrillation

By Will Morton

F-18 FDG uptake was more frequent in the atria and ventricles of patients with AFib compared to those without it.

January 20, 2026

MBI remains underused despite high performance

By Amerigo Allegretto

Molecular breast imaging (MBI) continues to be underused, with an overall decline in utilization between 2017 and 2022.

January 16, 2026

How does high alcohol use affect the brain?

By Will Morton

Synaptic density deficits are evident even in people with mild-to-moderate alcohol use disorder.

January 15, 2026

New theranostic pairing shows promise for upper gastrointestinal tumors

By AuntMinnie.com staff writers

A new theranostic pairing shows promise for detecting and effectively treating gastric and pancreatic tumors.

January 13, 2026

FAPI-PET shows promise in patients with liver fibrosis

By Will Morton

The technique outperformed standard blood-based and ultrasound exams.

January 12, 2026

Bayer acquires pan-amyloid radiotracers from Attralus

By AuntMinnie.com staff writers

Bayer plans to acquire from Attralus two investigational molecular imaging agents for the diagnosis of cardiac amyloidosis.

January 12, 2026

Theranostic pair ready for testing in lung cancer

By Will Morton

Gallium-68 (Ga-68) SSO120 PET/CT successfully visualized lesions in patients during and after chemotherapy.

January 8, 2026

Page 1 of 619

Next Page